General information about company |
|
|---|---|
| Scrip code | 544176 |
| NSE Symbol | AADHARHFC |
| MSEI Symbol | NOTLISTED |
| ISIN | INE883F01010 |
| Name of company | Aadhar Housing Finance Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-Apr-2024 |
| Date of end of financial year | 31-Mar-2025 |
| Date of board meeting when results were approved | 06-May-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 28-Mar-2025 |
| Description of presentation currency | INR (in Actuals) |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Housing Finance Business |
| Start date and time of board meeting | 06-May-2025 14:00:00 |
| End date and time of board meeting | 06-May-2025 15:50:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Financial Results — NBFC |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | |||
| (i) | Interest Income | 7224000000 | 27189900000 |
| (ii) | Dividend Income | 0 | 0 |
| (iii) | Rental Income | 0 | 0 |
| (iv) | Fees and commission Income | 543900000 | 1993500000 |
| (v) | Net gain on fair value changes | 69100000 | 222400000 |
| (vi) | Net gain on derecognition of financial instruments under amortised cost category | 489100000 | 1670500000 |
| (vii) | Sale of products (including Excise Duty) | 0 | 0 |
| (viii) | Sale of services | 0 | 0 |
| (ix) | Other revenue from operations | ||
| Total other revenue from operations | |||
| Total Revenue From Operations | 8326100000 | 31076300000 | |
| Other income | 12300000 | 12800000 | |
| Total income | 8338400000 | 31089100000 | |
| 2 | Expenses | ||
| Cost of materials consumed | 0 | 0 | |
| Purchases of stock-in-trade | 0 | 0 | |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | 0 | |
| Employee benefit expense | 1246900000 | 4644900000 | |
| Finance costs | 3147100000 | 11737700000 | |
| Depreciation, depletion and amortisation expense | 64500000 | 252400000 | |
| Fees and commission expense | 0 | 0 | |
| Net loss on fair value changes | 0 | 0 | |
| Net loss on derecognition of financial instruments under amortised cost category | 0 | 0 | |
| Impairment on financial instruments | 63900000 | 570700000 | |
| (f) | Other expenses | ||
| 1 | Other expenses | 656900000 | 2150800000 |
| Total other expenses | 656900000 | 2150800000 | |
| Total expenses | 5179300000 | 19356500000 | |
| 3 | Total profit before exceptional items and tax | 3159100000 | 11732600000 |
| 4 | Exceptional items | 0 | 0 |
| 5 | Total profit before tax | 3159100000 | 11732600000 |
| 7 | Tax expense | ||
| 8 | Current tax | 551500000 | 2492500000 |
| 9 | Deferred tax | 159200000 | 121800000 |
| 10 | Total tax expenses | 710700000 | 2614300000 |
| 11 | Net Profit Loss for the period from continuing operations | 2448400000 | 9118300000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 17 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 14 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
| 15 | Total profit (loss) for period | 2448400000 | 9118300000 |
| 16 | Other comprehensive income net of taxes | -38000000 | -38000000 |
| 17 | Total Comprehensive Income for the period | 2410400000 | 9080300000 |
| 18 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 0 | 0 | |
| Total profit or loss, attributable to non-controlling interests | 0 | 0 | |
| 19 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 0 | 0 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0 | 0 | |
| 20 | Details of equity share capital | ||
| Paid-up equity share capital | 4313800000 | 4313800000 | |
| Face value of equity share capital | 10 | 10 | |
| 21 | Reserves excluding revaluation reserve | ||
| 22 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings per share from continuing operations | 5.68 | 21.43 | |
| Diluted earnings per share from continuing operations | 5.55 | 20.85 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings per share from discontinued operations | 0 | 0 | |
| Diluted earnings per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings per share | 5.68 | 21.43 | |
| Diluted earnings per share | 5.55 | 20.85 | |
| 23 | Debt equity ratio | 0.0231 | 0.0231 |
| 24 | Debt service coverage ratio | 0.0 | 0.0 |
| 25 | Interest service coverage ratio | 0.0 | 0.0 |
| 26 | Disclosure of notes on financial results | ||
Remarks |
||
|---|---|---|
| 23 | Debt equity ratio | |
| 24 | Debt service coverage ratio | |
| 25 | Interest service coverage ratio | |
Cash flow statement, indirect |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| A | Date of start of reporting period | 01-Apr-2024 | |
| B | Date of end of reporting period | 31-Mar-2025 | |
| C | Whether results are audited or unaudited | Audited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Part I | Blue color marked fields are non-mandatory. | ||
| Statement of cash flows | |||
| Cash flows from used in operating activities | |||
| Profit before tax | 11732600000 | ||
| Adjustments for reconcile profit (loss) | |||
| Adjustments for finance costs | 11737700000 | ||
| Adjustments for decrease (increase) in inventories | 0 | ||
| Adjustments for decrease (increase) in trade receivables, current | -57500000 | ||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | ||
| Adjustments for decrease (increase) in other current assets | 0 | ||
| Adjustments for decrease (increase) in other non-current assets | 0 | ||
| Adjustments for other financial assets, non-current | 0 | ||
| Adjustments for other financial assets, current | -849100000 | ||
| Adjustments for other bank balances | 0 | ||
| Adjustments for increase (decrease) in trade payables, current | 0 | ||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | ||
| Adjustments for increase (decrease) in other current liabilities | 0 | ||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | ||
| Adjustments for depreciation and amortisation expense | 252400000 | ||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | ||
| Adjustments for provisions, current | 570700000 | ||
| Adjustments for provisions, non-current | 0 | ||
| Adjustments for other financial liabilities, current | 0 | ||
| Adjustments for other financial liabilities, non-current | -1970300000 | ||
| Adjustments for unrealised foreign exchange losses gains | 0 | ||
| Adjustments for dividend income | 0 | ||
| Adjustments for interest income | 27189900000 | ||
| Adjustments for share-based payments | 110200000 | ||
| Adjustments for fair value losses (gains) | 0 | ||
| Adjustments for undistributed profits of associates | 0 | ||
| Other adjustments for which cash effects are investing or financing cash flow | 0 | ||
| Other adjustments to reconcile profit (loss) | -219700000 | ||
| Other adjustments for non-cash items | 0 | ||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | ||
| Total adjustments for reconcile profit (loss) | -17615500000 | ||
| Net cash flows from (used in) operations | -5882900000 | ||
| Dividends received | 0 | ||
| Interest paid | 11674700000 | ||
| Interest received | 26219000000 | ||
| Income taxes paid (refund) | 2506700000 | ||
| Other inflows (outflows) of cash | -36421200000 | ||
| Net cash flows from (used in) operating activities | -30266500000 | ||
| Cash flows from used in investing activities | |||
| Cash flows from losing control of subsidiaries or other businesses | 0 | ||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | ||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | ||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | ||
| Other cash receipts from sales of interests in joint ventures | 0 | ||
| Other cash payments to acquire interests in joint ventures | 0 | ||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | ||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | ||
| Proceeds from sales of property, plant and equipment | 2100000 | ||
| Purchase of property, plant and equipment | 148000000 | ||
| Proceeds from sales of investment property | 0 | ||
| Purchase of investment property | 0 | ||
| Proceeds from sales of intangible assets | 0 | ||
| Purchase of intangible assets | 0 | ||
| Proceeds from sales of intangible assets under development | 0 | ||
| Purchase of intangible assets under development | 0 | ||
| Proceeds from sales of goodwill | 0 | ||
| Purchase of goodwill | 0 | ||
| Proceeds from biological assets other than bearer plants | 0 | ||
| Purchase of biological assets other than bearer plants | 0 | ||
| Proceeds from government grants | 0 | ||
| Proceeds from sales of other long-term assets | 0 | ||
| Purchase of other long-term assets | 0 | ||
| Cash advances and loans made to other parties | 0 | ||
| Cash receipts from repayment of advances and loans made to other parties | 0 | ||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | ||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | ||
| Dividends received | 0 | ||
| Interest received | 858900000 | ||
| Income taxes paid (refund) | 0 | ||
| Other inflows (outflows) of cash | 882300000 | ||
| Net cash flows from (used in) investing activities | 1595300000 | ||
| Cash flows from used in financing activities | |||
| Proceeds from changes in ownership interests in subsidiaries | 0 | ||
| Payments from changes in ownership interests in subsidiaries | 0 | ||
| Proceeds from issuing shares | 10360700000 | ||
| Proceeds from issuing other equity instruments | 0 | ||
| Payments to acquire or redeem entity's shares | 0 | ||
| Payments of other equity instruments | 0 | ||
| Proceeds from exercise of stock options | 0 | ||
| Proceeds from issuing debentures notes bonds etc | 10518000000 | ||
| Proceeds from borrowings | 48478600000 | ||
| Repayments of borrowings | 35263900000 | ||
| Payments of lease liabilities | 112300000 | ||
| Dividends paid | 0 | ||
| Interest paid | 0 | ||
| Income taxes paid (refund) | 0 | ||
| Other inflows (outflows) of cash | -88800000 | ||
| Net cash flows from (used in) financing activities | 33892300000 | ||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 5221100000 | ||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Effect of exchange rate changes on cash and cash equivalents | 0 | ||
| Net increase (decrease) in cash and cash equivalents | 5221100000 | ||
| Cash and cash equivalents cash flow statement at beginning of period | 3562600000 | ||
| Cash and cash equivalents cash flow statement at end of period | 8783700000 | ||
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Finanical Asset | ||
| Cash and cash equivalents | 8783700000 | ||
| Bank Balance other than (a) above | 8450100000 | ||
| Derivative financial instruments | 0 | ||
| Receivables | |||
| (I) Trade Receivables | 252800000 | ||
| (II) Other Receivables | 0 | ||
| Loans | 204841000000 | ||
| Investments | 5131800000 | ||
| Other Financial assets | 3474900000 | ||
| Total Financial Assets | 230934300000 | ||
| 2 | Non Financial Asset | ||
| Inventories | 0 | ||
| Current tax assets (Net) | 124400000 | ||
| Deferred tax Assets (Net) | 4200000 | ||
| Investment Property | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Property, Plant and Equipment | 315100000 | ||
| Capital work-in-progress | 0 | ||
| Intangible assets under development | 0 | ||
| Goodwill | 0 | ||
| Other Intangible assets | 603600000 | ||
| Other non-financial assets (to be specified) | 258000000 | ||
| Total Non Financial Assets | 1305300000 | ||
| Total assets | 232239600000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 4313800000 | ||
| Other equity | 59409100000 | ||
| Total equity attributable to owners of parent | 63722900000 | ||
| Non controlling interest | |||
| Total equity | 63722900000 | ||
| 2 | Liabilities | ||
| 2.1 | Financial Liabilities | ||
| (a) | Derivative financial instruments | 146700000 | |
| (b) | Payables | ||
| (I)Trade Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 2100000 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 1257200000 | ||
| II) Other Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| (C ) | Debt Securities | 33888200000 | |
| (d) | Borrowings (Other than Debt Securities) | 128732900000 | |
| (e) | Deposits | 5400000 | |
| (f) | Subordinated Liabilities | 597700000 | |
| (g) | Other financial liabilities | 3293000000 | |
| Total Financial Liabilities | 167923200000 | ||
| 2.2 | Non-Financial Liabilities | ||
| (a) | Current tax liabilities (Net) | 0 | |
| (b) | Provisions | 315700000 | |
| (C ) | Deferred tax liabilities (Net) | 21300000 | |
| (d) | Other non-financial liabilities | 256500000 | |
| Total Non Financial Liabilities | 593500000 | ||
| Total liabilities | 168516700000 | ||
| Total equity and liabilites | 232239600000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| Whether accounts are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Consolidated | Consolidated | |
| 1 | Segment Revenue (Income) | ||
| (net sale/income from each segment should be disclosed) | |||
| Total Segment Revenue | |||
| Less: Inter segment revenue | |||
| Revenue from operations | |||
| 2 | Segment Result | ||
| Profit (+) / Loss (-) before tax and interest from each segment | |||
| Total Profit before tax | |||
| i. Finance cost | |||
| ii. Other Unallocable Expenditure net off Unallocable income | |||
| Profit before tax | |||
| 3 | (Segment Asset - Segment Liabilities) | ||
| Segment Asset | |||
| Total Segment Asset | |||
| Un-allocable Assets | |||
| Net Segment Asset | |||
| 4 | Segment Liabilities | ||
| Segment Liabilities | |||
| Total Segment Liabilities | |||
| Un-allocable Liabilities | |||
| Net Segment Liabilities | |||
| Disclosure of notes on segments | |||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the defined employee benefit plans | 2200000 | 2200000 |
| Total Amount of items that will not be reclassified to profit and loss | 2200000 | 2200000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 500000 | 500000 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | The effective portion of gains and loss on hedging instruments in a cash flow hedge | -53000000 | -53000000 |
| Total Amount of items that will be reclassified to profit and loss | -53000000 | -53000000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | -13300000 | -13300000 |
| 5 | Total Other comprehensive income | -38000000 | -38000000 |
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Kirtane & Pandit LLP | Yes | 31-Dec-2025 | ||
|---|---|---|---|---|---|
| 2 | S. R. Batliboi & Associates LLP | Yes | 31-Jul-2027 | ||
Financial details |
|||
| Sr. | Particulars | Audited Figures (as reported before adjusting for qualifications) | Adjusted Figures (audited figures after adjusting for qualifications) |
| 1 | Turnover / Total income | ||
| 2 | Total Expenditure | ||
| 3 | Net Profit/(Loss) | ||
| 4 | Earnings Per Share | ||
| 5 | Total Assets | ||
| 6 | Total Liabilities | ||
| 7 | Net Worth | ||
Signatories details |
|
|---|---|
| Name of CEO / Managing director | |
| Name of CFO | |
| Name of audit committee chairman | |
| Name of statutory auditor | |
| Name of other signatory, if any, with designation | |
| Place | |
| Date | |